Theranostics Q1 Unclaimed
Theranostics is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 177. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1525 €. The scope of the journal is focused on in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, personalized medicine. It has an SJR impact factor of 3,37 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,37.
Theranostics focuses its scope in these topics and keywords: cancer, nanoparticles, theranostic, vivo, breast, imaging, receptors, tumor, biomarkers, blocking, ...
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1525 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,37
SJR Impact factor177
H Index405
Total Docs (Last Year)1349
Total Docs (3 years)32645
Total Refs18548
Total Cites (3 years)1349
Citable Docs (3 years)12.72
Cites/Doc (2 years)80.6
Ref/DocOther journals with similar parameters
MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1
Compare this journals
Comments